Salem Health West Valley

Salem Health West Valley was paid $16.20M by Medicaid between Jan 2018 and Dec 2024, across 102 billing codes. Its largest line is 99283, emergency room visit (moderate) — 42% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	16,304	$1.24M
2019	18,279	$1.38M
2020	21,342	$851K
2021	34,781	$1.21M
2022	36,793	$1.54M
2023	41,619	$5.07M
2024incomplete	31,063	$4.92M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	42%	36,928	29,149	$6.82M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	32%	21,595	16,816	$5.18M
80053	Comprehensive metabolic panel	4.6%	19,866	18,190	$748K
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	3.1%	1,415	1,082	$501K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	1.9%	5,815	5,300	$305K
87631		1.8%	2,265	2,102	$296K
99282	Emergency department visit for the evaluation and management, low to moderate severity	1.4%	2,071	1,799	$220K
74177	Computed tomography, abdomen and pelvis; with contrast material	1.3%	522	489	$208K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	1.2%	19,407	17,612	$187K
96375	Therapeutic injection; each additional sequential IV push	1.1%	3,075	2,737	$176K
36415	Collection of venous blood by venipuncture	<1%	22,961	20,559	$158K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	642	607	$122K

90 more codes

87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	2,489	$117K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	3,446	$115K
81001		<1%	10,572	$115K
99214	Doctor's office visit, returning patient (more involved)	<1%	5,379	$84K
99213	Doctor's office visit, returning patient (routine)	<1%	4,733	$84K
71046	Radiologic examination, chest; 2 views	<1%	1,241	$62K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	206	$51K
84443	Thyroid stimulating hormone (TSH)	<1%	1,830	$50K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	1,027	$47K
80061	Lipid panel	<1%	1,894	$43K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	515	$40K
83036	Hemoglobin; glycosylated (A1C)	<1%	2,116	$38K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	1,583	$35K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	957	$34K
0012A		<1%	1,529	$31K
84484		<1%	1,351	$27K
0011A		<1%	1,640	$25K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	286	$24K
80048	Basic metabolic panel (calcium, ionized)	<1%	617	$24K
70450	Computed tomography, head or brain; without contrast material	<1%	145	$23K
71045	Radiologic examination, chest; single view	<1%	483	$22K
0001A		<1%	539	$17K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	226	$16K
J7030	Infusion, normal saline solution , 1000 cc	<1%	5,945	$15K
0002A		<1%	461	$15K
83690		<1%	1,508	$15K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	1,874	$11K
87086	Culture, bacterial; quantitative colony count, urine	<1%	537	$10K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	56	$10K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	2,695	$10K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	1,662	$7K
90686		<1%	553	$7K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	79	$7K
81025		<1%	471	$5K
99203	Doctor's office visit, new patient (routine)	<1%	160	$5K
83735		<1%	252	$5K
86803		<1%	102	$4K
80306		<1%	41	$3K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	44	$3K
85027		<1%	196	$3K
0004A		<1%	97	$3K
0064A		<1%	82	$2K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	132	$2K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	43	$2K
85730		<1%	60	$2K
84145		<1%	12	$2K
96361	Intravenous infusion, hydration; each additional hour	<1%	124	$1K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	14	$1K
87077		<1%	33	$689.65
96160		<1%	166	$491.18
0071A		<1%	12	$444.80
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	15	$405.93
99204	Doctor's office visit, new patient (more involved)	<1%	16	$388.92
J2270	Injection, morphine sulfate, up to 10 mg	<1%	167	$386.72
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	34	$385.80
83718		<1%	27	$351.24
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	88	$346.90
84478		<1%	27	$323.19
90715		<1%	15	$306.52
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	13	$304.73
87081		<1%	70	$284.96
83605		<1%	39	$193.35
J7120	Ringers lactate infusion, up to 1000 cc	<1%	141	$173.02
87070		<1%	13	$161.02
G0444	Annual depression screening, 5 to 15 minutes	<1%	12	$157.68
82248		<1%	13	$138.36
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	29	$128.80
82553		<1%	43	$127.28
J1790	Injection, droperidol, up to 5 mg	<1%	29	$108.32
J3490	Unclassified drugs	<1%	18	$107.95
82550		<1%	43	$96.35
85379		<1%	15	$96.14
90651		<1%	17	$91.74
85610		<1%	93	$82.20
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	13	$79.80
82728		<1%	13	$71.06
96127		<1%	13	$69.60
99173		<1%	101	$68.38
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	85	$59.38
81003		<1%	13	$52.00
82607		<1%	13	$46.36
82746		<1%	13	$44.84
82150		<1%	16	$43.12
83540		<1%	13	$38.81
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	12	$34.30
99442		<1%	50	$27.20
84703		<1%	28	$10.52
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	12	$8.43
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	16	$0.17
99406		0%	16	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPARR, JAMES (EXEC VP AND CFO)